Learning Center
Plans & pricing Sign in
Sign Out

2012 | Mycoses – Pipeline Review, H2 2012

 announces, The Latest market research report is available in
its vast collection:

Mycoses – Pipeline Review, H2 2012

You can also request for sample page of above mention reports on


Global Markets Direct’s, Mycoses - Pipeline Review, H2 2012, provides an overview
of the Mycoses therapeutic pipeline. This report provides information on the
therapeutic development for Mycoses, complete with latest updates, and special
features on late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Mycoses. Mycoses - Pipeline Review,
H2 2012 is built using data and information sourced from Global Markets Direct’s
proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.


- A snapshot of the global therapeutic scenario for Mycoses.
- A review of the Mycoses products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
Table of contents:

List of Tables 5
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Mycoses Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for Mycoses 10
Mycoses Therapeutics under Development by Companies 12
Mycoses Therapeutics under Investigation by Universities/Institutes 16
Late Stage Products 18
Comparative Analysis 18
Mid Clinical Stage Products 19
Comparative Analysis 19
Early Clinical Stage Products 20
Comparative Analysis 20
Discovery and Pre-Clinical Stage Products 21
Comparative Analysis 21
Mycoses Therapeutics – Products under Development by Companies 22
Mycoses Therapeutics – Products under Investigation by Universities/Institutes 26
Companies Involved in Mycoses Therapeutics Development 27
Valeant Pharmaceuticals International 27
BioDelivery Sciences International, Inc. 28
Daiichi Sankyo Company, Ltd 29
Merck & Co., Inc. 30
Stiefel Laboratories, Inc. 31
Quinnova Pharmaceuticals, Inc. 32
Dr. Reddys Laboratories Limited 33
Pfizer Inc. 34
Sigma-Tau S.p.A. 35
Bayer AG 36
Helix BioMedix, Inc. 37
iCo Therapeutics Inc. 38
Immtech Pharmaceuticals, Inc. 39
Almirall, S.A. 40
Basilea Pharmaceutica Ltd. 41
MethylGene Inc 42
NexMed, Inc. 43
NovaBay Pharmaceuticals, Inc. 44
Nuvo Research Inc. 45
Pacgen Biopharmaceuticals Corporation 46
Pevion Biotech Ltd 47
Hisamitsu Pharmaceutical Co., Inc. 48
Xel Pharmaceuticals, Inc. 49
Evolva SA 50
Novabiotics Ltd 51

List of Figures

List of Tables are also include.

For more related Reports Plz follow The link:

Pipeline Review, H2 2012 Review, H2

Movement Disorders – Pipeline Review, H2 2012

Bone Metastasis – Pipeline Review, H2 2012

Cognitive Impairment – Pipeline Review, H2 2012

Mycoses – Pipeline Review, H2 2012

Skin Inflammation – Pipeline Review, H2 2012

Kidney Disease – Pipeline Review, H2 2012
Allergies – Pipeline Review, H2 2012

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) – Pipeline
Review, H2 2012

Transplantation – Pipeline Review, H2 2012

Liver Transplantation – Pipeline Review, H2 2012

Myelodysplastic Syndrome – Pipeline Review, H2 2012

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare and

For More details Plz do contact :

Aarkstore Enterprise




To top